Inventiva (IVA) Share-based Compensation (2020 - 2022)

Inventiva (IVA) recorded quarterly Share-based Compensation of -$128551.2 in Q4 2022, down 766.08% quarter-over-quarter from $19299.8 in Q1 2021.

Inventiva (IVA) Share-based Compensation (2020 - 2022) Analysis & Trends

Inventiva's Share-based Compensation history runs 3 years deep, the most recent figure standing at -$128551.2 for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	305,000.00
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	166.40 Mn
9	Abivax	95.45 Bn	95.45 Bn	-	26.47 Mn
10	Inventiva	8.93 Mn	-259.80 Mn	-	-

Download Data